Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000186

Chairperson & CEO sold 9,500 shares at an average $586.32 ($5,570,085)

  • Chairperson & CEO acquired 9,500 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

ROTHBLATT MARTINE A · Chairperson & CEO

Table I: Non-derivative

15 lines
Date Transaction Shares Price Value Owned after D/I
2026-11-10 Exercise or conversion : show line 1 in the form 10b5-1 +9,500 $117.76 $1,118,720 333,943 I
2026-11-10 Sale : show line 2 in the form 10b5-1 −40 $577.52 $23,101 333,903 I
2026-11-10 Sale : show line 3 in the form 10b5-1 −880 $580.40 $510,756 333,023 I
2026-11-10 Sale : show line 4 in the form 10b5-1 −742 $581.36 $431,367 332,281 I
2026-11-10 Sale : show line 5 in the form 10b5-1 −618 $582.42 $359,937 331,663 I
2026-11-10 Sale : show line 6 in the form 10b5-1 −980 $583.64 $571,964 330,683 I
2026-11-10 Sale : show line 7 in the form 10b5-1 −328 $584.76 $191,801 330,355 I
2026-11-10 Sale : show line 8 in the form 10b5-1 −795 $585.56 $465,517 329,560 I
Open-market sales · 9,500 sh · avg $586.32 · $5,570,085

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-11-10 Exercise or conversion : show line 16 in the form 10b5-1 Stock Option −9,500 52,910 I
Loading xslF345X06/primarydocument.xml…